Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma

Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma

(2011) Emily Ruden et al.   JOURNAL OF CLINICAL ONCOLOGY

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer

(2011) Jeffrey S Wefel et al.   LANCET ONCOLOGY

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

(2011) MJ van den Bent et al.   LANCET ONCOLOGY

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

(2011) J. S. Wefel et al.   NEURO-ONCOLOGY

Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma

(2010) Jing Li et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Trail Making Test Predicts Physical Impairment and Mortality in Older Persons

(2010) Rosamaria Vazzana et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC

(2009) A.M. STARK et al.   EUROPEAN JOURNAL OF CANCER CARE

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

(2009) Michael Weller et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System

(2009) Edward F. Chang et al.   JOURNAL OF NEUROSURGERY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

(2007) Thierry Gorlia et al.   LANCET ONCOLOGY